Abstract. In this study we investigate the causal impact of increasing adult longevity on higher education. We exploit the fourth stage of the epidemiological transition, i.e. the unexpected decline of deaths from heart attack and stroke in the 1970s as a large positive health shock that affected predominantly old age mortality. Using a differences-indifferences estimation strategy we find across U.S. states that the cardiovascular revolution led to an increase in adult life expectancy by about 2 years, which caused higher education enrollment to increase by 7 percentage points, i.e. 30 percent of the observed increase from 1970 to 2000. Our findings are robust to the inclusion of state-specific health trends and a host of confounding variables. They suggest large effects of improving longevity on higher education enrollment.
Introduction
One of the most controversial issues in the economics of long-run development is whether the increasing life expectancy, observable across the world during the 20th century, exerted a positive effect on the evolution of per capita income (e.g., Acemoglu and Johnson, 2007; Lorentzen et al., 2008; Cervellati and Sunde, 2011) . The most obvious channel for a positive income effect is based on the higher incentive to invest in education induced by the expectation of a longer life. In theory, this mechanism was established more than 40 years ago (Ben-Porath, 1967 ). In practice, the relevance of the Ben-Porath mechanism has been recently challenged by Hazan's (2009) study, which then triggered a series of refinements of the original theory (Hansen and Lønstrup, 2012; Strulik and Werner, 2012; Cervellati and Sunde, 2013) . In this paper we attempt to shed new light on these issues with an empirical strategy that captures the ideas of the original Ben-Porath model more closely than the existing literature by focussing on the impact of adult longevity on higher education.
The existence of a strong positive association between life expectancy and education is a well documented fact. According to one popular study, US Americans aged 25 in the year 2000 lived 7 years longer with any college education compared to those with only high school education or less (Meara et al., 2008) . In many other countries a similar association between education and health has been observed. One of the major problems, however, hampering identification of the impact of longevity on education is reverse causality. Several mechanisms are conceivable generating a positive impact of education on longevity (e.g., Grossman, 2006; Strulik, 2013 ) and there exists a rich microeconometric literature suggesting that indeed a part of the observable in the 1940s had no impact on deaths from cardiovascular disease, which were continuously on the rise from the beginning of the 20th century until about 1970 (American Heart Association,
2014, Chart 13-4).
The focus on communicable diseases and infant and child mortality, which follows inevitably from using the third stage of the epidemiological transition as a health shock, appears to be less appropriate to uncover the nexus between longevity and education for several reasons. Firstly, it is already conceivable from theory that lower child mortality causes human capital per capita to decline. This may be the case because of the scarring effect of diseases such that cured survivors perform worse at school than non-infected children (Aksan and Chakraborty, 2014 , see e.g. Snow et al., 2003, and Bleakley, 2007 for evidence). Secondly, education of children is either compulsory or decided upon by their parents. According to standard economic theory parents would decide jointly on the number and education of their children. In this respect the conventional overlapping generation model predicts that improving child mortality should leave net fertility and thus education unchanged (Galor, 2005 (Galor, , 2011 while the Becker-Barro model as well as extensions of the OLG model predict increasing net fertility (Doepke, 2005; Strulik and Weisdorf, 2014) , a response which is confirmed by time series analysis Eckstein et al., 1999; Herzer et al., 2012) . Increasing net fertility, in turn, would delay the fertility transition and the take-off of education and economic growth. These considerations are consistent with results from Cervellati and Sunde (2011) showing that increasing life expectancy had a positive effect on income per capita only in those countries, in which net fertility declines as a response to declining child mortality, i.e. in countries where the demographic transition had advanced far already in 1940. One interpretation of their result could be, in light of the present paper, that life expectancy at birth in these countries was strongly correlated with adult life expectancy because child mortality was already very low.
A paper which, like us, focusses on adult mortality is provided by Lorentzen et al. (2008) .
This study, however, refrains from exploiting a health shock for identification and uses instead malaria ecology, climatic variables, and geographic features as instruments. Yet again, these instruments capture predominantly exogenous influences on deaths from communicable diseases and are presumably less suitable to capture the influence of natural aging and non-communicable diseases. Lorentzen et al. (2008) find that adult mortality, instrumented in this way, exerts a significant effect of on growth, investment, and fertility but, like Acemoglu and Johnson (2006) , they fail to establish a significant effect on average years of schooling in the population. A recent study by Hansen (2013a) , in contrast, demonstrates a positive effect of increasing life expectancy on years of schooling using a cohort based measure and the identification strategy of Acemoglu and Johnson (2006, 2007) . Inspecting different potential drivers of these results, the study concludes that declines in pneumonia mortality seem to be mainly responsible. Interestingly, lower respiratory infections (including pneumonia) come fourth, after the cardiovascular diseases, as the leading cause of death for adults aged 60+ (WHO, 2008).
The question, however, remains what can be learned from the epidemiological transition of the 1940s or, more generally, from the historical decline of communicable diseases for the future of longevity and higher education in developed countries. In developed countries, primary and secondary education is largely compulsory and tertiary education, i.e. the decision to go to college or university is presumably made by adults on their own behalf, in line with the assumptions of the original Ben-Porath model and its implementation in theories of long-run growth (Boucekinne et al., 2002; Sunde, 2005, 2014) . These adults experience little threat of dying prematurely from communicable diseases, which are affecting predominantly the mortality of children in developing countries. Instead they face the risk of dying in old age by non-communicable diseases, most importantly by heart attack and stroke. Human capital from tertiary education, moreover, is presumably the most important input in R&D and thus the ultimate driver of productivity growth (Strulik, 2005; .
In order to uncover the causal effect of adult life expectancy on higher education we develop a new instrument, namely the strong, permanent, and unexpected decline of death from heart disease and stroke that began in the 1970, and has been dubbed the cardiovascular revolution (Foege, 1987; Vallin and Mesle, 2009; Thelle, 2011) . We focus on education enrollment of 18 to 24 old US-Americans and on life expectancy at 30 (or, alternatively, at 50). This means that there is already by design relatively little concern for reverse causality, i.e. that the education decision of 18-24 year old may affect life expectancy of the contemporaneously 30 or 50 year old. Measurement error and time varying omitted variables, however, are still an issue, which we attempt to take care of with our instrumental variable approach, which follows the same principal logic as the empirical strategies employed in, e.g., Bleakley (2007) , Acemoglu and Johnson (2007) , and Hansen (2014) .
The paper is organized as follows. The next section introduces the cardiovascular revolution. Section 3 and 4 describe the data and estimation strategy. Section 5 establishes the impact of the cardiovascular revolution on adult life expectancy and Section 6 presents our main results on the impact of adult longevity on higher education enrollment. Section 7 concludes.
The Cardiovascular Revolution
It may be illuminating to begin with some insights from gerontology in order to contrast our approach with the existing health-shock literature. In gerontology there exists a very strong association between age and the force of mortality, i.e. the conditional probability to die in the next period (e.g., Arking, 2006) . This association, known as Gompertz-Makeham law, is formally given by µ = A + Re αx , in which x is age and µ is the force force of mortality. The parameter A captures "background mortality", i.e. age-unrelated causes of death, whereas the parameters R and µ capture the impact of aging on mortality. In human history, background mortality has come down big time, particularly during the epidemiological transition of the 1940s, and it is now close zero in developed countries (Gavrilov and Gavrilova, 1991) . In developed countries most people die from degenerative, aging related diseases whose impact is covered by initial frailty R and the speed of increasing mortality with age α.
It is easy to see that any positive trends of life expectancy would soon come to an end if the trend were solely determined by falling background mortality, including the prevention and treatment of communicable diseases. Life expectancy would converge towards a constant life span determined by the aging parameters R and α. The observation that life expectancy does not (yet) seem to converge, i.e. that we observe "broken limits to life expectancy" (Oeppen and Vaupel, 2002 ) indicates that we, unlike all other animals, managed to manipulate the aging process itself. Inspecting the aging parameters we find indeed evidence that since the 1970s not only life expectancy (a population-specific characteristic) but also human life span (a species-characteristic) is on the rise . The most likely driver of this "manufactured life-time" (Carnes and Olshansky, 2007 ) is medical technological progress that interfered with the natural way of human aging. The observation that human life span seems to be manipulated for the first time in the 1970 inspired our research on the cardiovascular revolution.
"Man is as old as his arteries". This old aphorism, cited according to Dantas et al. (2012) , describes succinctly that cardiovascular diseases are degenerative and inevitably related to the "natural" process of human aging.
1 Our arteries are simply not built to last. They dilate and stiffen through natural physical stress and fatigue (Ungvari et al., 2010) . The most common type of heart disease and cause of heart attacks is coronary heart disease also known ischemic heart disease. It is caused by plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and reduces the blood flow to the heart.
Given that background mortality is continuously declining such that humans die increasingly of degenerative, aging-related diseases, we would expect that the incidence of death from cardiovascular diseases increases over time. Indeed, extrapolating historical trends for US-Americans, the National Heart, Lung, and Blood Institute expected about 1.6 million deaths of coronary heart disease (i.e. an age-adjusted death rate of 0.55 percent) at the end of the 20th century while actually it were "only" 0. [ Figure 1 about here]
1 In biology aging is understood as the "intrinsic, cumulative, progressive, and deleterious loss of function that eventually culminates in death" (Arking, 2006) . For an introduction to the evolutionary foundations of human aging see Kirkwood (1999) . For a detailed formal description of the aging process by reliability theory see Gavrilov and Gavrilova (1991 We capture the intensity of the health shock by the number of deaths due to major cardiovascularrenal diseases per 100 white people (age adjusted), measured prior to the breakthroughs in the understanding of cardiovascular diseases (i.e., in 1960). This variable is gathered from Grove and Hetzel (1968) and is referred to as CVD. Figure 2 shows that Northeastern states generally have higher levels CVD.
Motivated by the evidence described in Section 2, we code the (medical) interventions, which are argued to have decreased mortality from cardiovascular diseases, as occurring after the 1960s.
This means that the time indicator (Post) equals one from 1970 onwards. We use the interaction between these two variables (i.e., CVD · Post) to estimate how the decline of cardiovasculardisease mortality influenced the subsequent development of life expectancy and education. This health-shock variable constitutes the IV in our 2SLS strategy, and we refer to it to as the CVD shock.
To control for the possible influence of non-cardiovascular mortality on life expectancy, we also construct the variable Initial Mortality, which is the age-adjusted mortality rate from the causes of death that are not attributable to cardiovascular diseases in 1960. This variable is also obtained from Grove and Hetzel (1968) and interacted with the time indicator.
Finally, we consider the following variables (measured in 1960): average years of schooling in the workforce, log GDP per capita, and log capital per worker. These variables are taken from Turner et al. (2007), and, to account for this variation in our regressions, they are also interacted with the time indicator. In addition, we report results from specifications that control directly for log GDP per capita.
[ Table 1 about here]
[ Figure 2 about here]
3.2. Pretreatment Differences in the Outcomes. Because our empirical strategy exploits a differences-in-differences (DD) application to estimate the effect of the cardiovascular revolution on life expectancy and education (see also the next section), the identifying assumption is identical pretreatment trends in the outcomes between treatment and control states. Due to the continuous nature of the treatment, this is the same as saying that CVD should be uncorrelated with changes in the outcomes before treatment. Therefore, as an initial step of testing this assumption, we now explore pretreatment differences in the level and the change of the outcomes for states with different levels of CVD. In the level specification, we regress the outcome j in state s (Y j s ) on the cardiovascular mortality rate in 1960 (CVD s ):
where X s is vector of controls and ε s is the error term. The estimated β j reflects pretreatment (conditional) differences in the outcome j for states with different mortality rates from cardiovascular diseases in 1960. Before turning to our change specification, it is important to note thatβ j = 0 does necessarily imply that the identifying assumption is violated as the DD model allows us to non-parametrically control for state fixed effects.
In the change specification, we regress the pretreatment changes in the outcome between 1940
and 1960 (∆Y j s ) on CVD s and X s :
The estimate of β ∆ j provides the same information as a falsification exercise testing if the CVDshock variable (CVD · Post) in the DD model has any predictive power for the development of the outcomes in the pretreatment period (i.e., . Ifβ ∆ j = 0 cannot be rejected, the falsification test would support the identifying assumption of common pretrends. Table 2 reports weighted least squares estimates of β j and β ∆ j in equations (1) and (2), respectively. Columns 2 and 4 report the unconditional estimates, whereas columns 3 and 5 report these estimates conditional on two or three state-level controls.
2 Unsurprisingly, the relationship between life expectancy at age 30 (or 50) in 1960 and CVD is negative and statistically significant at the 1 percent level (columns 2 and 3). More importantly, however, we also find that CVD is completely unrelated to changes in life expectancy between 1940 and 1960, which imply that the CVD shock has no any predictive power for life expectancy in the pretreatment period (columns 4 and 5). Figure 3 shows graphically that this lack of relationship is not driven by some outlier states.
Furthermore, the estimates reported in Table 2 reveal that states with different rates of cardiovascular-disease mortality were similar in terms of higher education enrollment and schooling enrollment at age 18-24 in 1960 , and that these states experienced similar changes between 1940 and 1960 in the schooling enrollment age 18-24. This suggests that the CVD-shock variable is not likely to capture preexisting different trends in the education outcomes.
[ Table 2 and Figure 3 about here]
Empirical Framework
This section explains our main estimation strategy. We use an instrumental-variable approach to identify the effect of life expectancy on education. The second-stage relationship in that framework is given by the following estimation equation:
where Y st is the higher education enrollment rate (or the school enrollment rate age [18] [19] [20] [21] [22] [23] [24] for the white population in state s at time t. In our baseline specification, we consider the model using the two years: t 1 = 1960 and t 2 = 2000. The main variable of interest is life expectancy at age 30 (or 50) for the white population (Life Expectancy st ). We also include a vector of controls (X s )
containing the age-adjusted mortality rate from non-CVD causes, the initial enrollment rate, initial log GDP per capita. These cross-sectional variations are measured in 1960 and interacted with the indicator (Post t ), which equals one in the years after 1960. The panel structure of our dataset allows us to non-parametrically control for state (λ s ) and time (τ t ) fixed effects. We cluster the error term ( st ) at the state level, ensuring that the standard errors of our estimates are robust to arbitrary serial correlation in the states (e.g., Cameron and Miller, 2013) .
The main first-stage specification is:
where CVD s is the age-adjusted death rate from major cardiovascular-renal diseases for the white population in 1960. The remaining variables are as defined above. The baseline specification estimates equation (4) Because the uptake of the new cardiovascular-disease fighting technologies is endogenous, we exploit the fact that some states stood to benefit more from the shock as they had higher levels of cardiovascular-disease mortality prior to the breakthrough. Following this approach, our estimate ofπ should not be biased by the different rates of actual adoption of the new technologies. In other words, we are measuring the intention-to-treat effect with the estimation ofπ, which is smaller than the average causal effect of on those who were actually treated (Angrist and Pischke, 2008) . This means thatπ provides a conservative estimate of how the cardiovascular revolution influenced the development of life expectancy.
Our instrument for life expectancy (CVD s · Post t ) computes the DD estimate of the shock to cardiovascular-disease mortality in the 1970s since we are comparing the relative change in life expectancy in the pretreatment period relative to the posttreatment period between states with different treatment intensities (i.e., CVD s ). As also argued in previous section, the main issue in the DD model is to check for pretrends in the outcomes that are correlated with the intensity of treatment. While the results in Tables 2 indicate that this is indeed not the case, we also estimate a fully flexible model that takes the following form:
where the only difference to equation (5) assumption is π k = 0 ∀k < 1970, whereas as the effect after treatment could increase, decrease or stay constant. This means, in contrast to the pretreatment π j s, that theπ j s ∀k ≥ 1970 are allowed not be identical.
Cardiovascular Diseases and Life expectancy
As a first step in our empirical analysis, this section presents the result from estimating the first-stage relationship. Throughout the analysis, the regressions include state and year fixed effects and are weighted by the white population in 1960, implying that the estimates reflect the average effect for a white individual in the US. This section is structured to gradually build up from the flexible-estimation approach, which is used to validate our identifying assumption of common pretrends, to the main DD estimate of the CVD shock (i.e., the first stage) used to the identify the effect of life expectancy on enrollment rate in Section 6. Columns 2 and 3 add controls for the initial mortality environment (measured by the death rate from non-cardiovascular diseases), initial log GDP per capita, and the initial higher education enrollment rate. In order to estimate the contribution of these cross-sectional measures, they are interacted with the time indicator as all the specifications include state-fixed effects.
Flexible Estimates.
We find that the inclusion of these controls reinforces the observed pattern of the estimated coefficients in column 1. Interestingly, the effect of the initial mortality environment is positive but highly insignificant, indicating that the decline in cardiovascular-disease mortality was the main contributor to the increase in life expectancy during this period. It should also be noted that the same pattern, though slightly more precisely estimated, is obtained by controlling flexibly for the cross-sectional measures, that is, interacting them with time-period fixed effects instead of the indicator.
In an unreported specification, we also included state-specific linear time trends to column 4 Thus, our basic conclusion, derived from the evidence reported in Table 3 , survives in this much more demanding specification.
Columns 4-6 report the evidence for life expectancy at age 50. We arrive at the same conclusion that there are no trends of the estimated interaction effects prior to the cardiovascular revolution, whereas by 1970 "more treated" states begin to experience greater increases in life expectancy. Overall, the identifying assumption in the DD framework of common pretrends is strongly supported by the evidence reported in Table 3 .
[ Table 3 about here]
Before turning to our main first-stage relationship, Table 4 reports the results from estimating equation (5) [ Table 4 about here]
5.2. The First-Stage Relationship. Table 5 Table 4 ), the effects are generally larger in magnitude. 5 The only difference to the flexible model being that we now estimate the interaction between CVD and the indicator variable rather than the time-period fixed effects 6 Data from the National Heart, Lung, and Blood Institute indicate that the cardiovascular disease mortality rate decreased by about 50 percent from 1970-2000. Before reporting the evidence from the robustness analysis, it is noteworthy that similar results are obtained for life expectancy age 50 (columns 4-6) and the estimated coefficient on the interaction Initial Mortality ·Post is negative but statistically highly insignificant in all the reported specifications.
[ Table 5 about here]
[ Figure 4 about here] Notice that these differences are not statistically significant. 8 This implies that only the 48 contiguous states are included in this particular robustness check. 9 As Hansen (2013b) demonstrates that states with higher levels of infectious disease mortality in 1940 experienced greater increase in human capital between 1950 and 2000, the CVD-shock variable could be picking this pretrend up. Moreover, in an unreported specification, we find that infectious disease mortality in 1940 does not predict the development of life expectancy at age 30 or 50 but only life expectancy at birth. This finding is consistent with infectious-disease mortality was weighted towards child mortality.
[ Table 6 about here] Table 7 considers various extensions to the baseline specification for life expectancy at age 30. 10 The first four columns add potential confounders. Firstly, columns 1-3 demonstrate that our conclusion is robust to initial variation in average years of schooling in the workforce and physical capital per worker (both interacted with the indicator). For example, subject to both controls in column 3, the estimated coefficient increases in magnitude to 16.28 (s.e. = 2.88).
Secondly, while log income per capita is likely to be a bad control variable, columns 4 reveals that the effect of the shock to life expectancy remains reassuringly stable in both magnitude and statistical significance controlling for log income per capita (i.e., Income).
The remaining columns report the results from various sample splits. Columns 5-7 make the split by geographical area. This evidence demonstrates that our first-stage relationship seems mainly to be driven by Northern and Southern states as we find positive and statistical significant relationships in these sub samples, whereas the coefficient estimate for the Western states is 7.43 (s.e. = 8.48). Nevertheless, as an alternative check along the same lines, estimating a model for the full sample of US states, which non-parametrically takes into account the variation occurring between these three regions over time by including region-by-year fixed effects, we find that the estimate of the first-stage continues to be positive and statistically significant at the 5 percent level (π = 11.90; s.e.= 5.00). This finding documents that the effect of the shock on life expectancy is not only driven by variation between states in the north and west as the map in Figure 2 of the geographical distribution of CVD could indicate.
The final two columns of the table report the results from splitting the sample into rich and poor states as measured by median GDP per capita in 1960. The effect is larger for initially poor states, however, the difference in point estimates is not statistically significant. Nonetheless, for a one-standard-deviation increase in CVD among the poor states, life expectancy increases by 0.54 years, while the point estimate for the rich states suggests an increase of 0.43 years.
[ Table 7 about here] 10 The robustness results for life expectancy at age 50 are not reported in order to save space. However, they are available upon request.
Life expectancy and Higher Education

Main results.
We turn now to our main empirical results in which we attempt to establish a causal relationship between the higher education enrollment rate and life expectancy. Table   8 estimates, a one-standard-deviation increase in CVD is associated with 2 percentage points increase in the enrollment rate.
[ Table 8 about here]
[Figures 5 about here] Table 9 presents the same type of evidence for the schooling enrollment rate age 18-24 as the outcome variable. As also mentioned in the data section, this extension is necessary in checking for differential pretrends in enrollment as the US Census does not provide any information on the degree attending before 1960. Nonetheless, the schooling enrollment rate age 18-24 appears to be a reasonable proxy for the higher education enrollment rate. The correlation is 0.99 in the years for which data on both variables are available (i.e., in our case 1960 and 2000). The LS and 2SLS estimates, reported in Table 9 , are similar in magnitude and significance to the estimates with the higher education enrollment rate as outcome, and Figure 6 also graphs similar reducedform relations. Next, we augment these long-panel specifications for schooling enrollment with the pretreatment year 1940 and subject them to state-specific trends. The 2SLS estimates in Table 10 show little change to this robustness test.
[ Tables 9 and 10 Finally, we study the robustness of the 2SLS estimates for life expectancy at age 30 with the higher education enrollment rate as the outcome variable. Inspecting the estimated coefficients presented in Table 11 , we see that the effect of life expectancy on the education is not driven by some convergence process in education related to the initial level of enrollment, years of schooling in the workforce, or income (columns 1-4). Moreover, motivated by the observation that CVD is generally larger in Northern and Southern states, we have also checked whether the effect is explained by the fact that states in these areas historically had more colleges, and this historical persistence could have produced a head start when college education became more widespread in the second half of the 20th century. When we accounted for this possible explanation by including the (state) number of permanent colleges before 1860 interacted with the indicator, the baseline estimate remained positive and significant (not reported). We also see from column 4 that the 2SLS estimate on life expectancy is not influenced by controlling for log income.
The results from the sample splits, reported in columns 5-9 demonstrate that the effect is prevalent in the Northern and Southern states, and in initially rich and poor states, whereas there is no effect considering states in the West only. Although the first-stage F-statistics in columns 5-8 are below 10, our conclusions seem not to be driven by weak first stages as indicated by the p-values from Anderson-Rubin Wald tests reported below the first-stage F-statistics.
[ Table 11 about here] . The left-hand-side variables are: life expectancy at age 30, life expectancy at age 50, the higher education (net) enrollment rate for the white population, the schooling enrollment rate age 18-24. Pretreatment level refers to the level of the outcome in 1960, whereas pretreatment changes refers to the change in the outcome in the period 1940-1960. For the life expectancy outcomes the covariates are: the number of deaths from all other causes than CVD per 100 white population in 1960; the higher education enrollment rate for the white population in 1960; log GDP per capita in 1960. For the schooling outcomes the covariates are: the number of deaths from all other causes than CVD per 100 white population in 1960; log GDP per capita in 1960. Constants and controls are not reported. Standard errors are robust clustered at the state level. *** p<0.01, ** p<0.05, * p<0.1. 
(8)
Life Expectancy at age 30 0.0420*** 0.0377*** 0.0359*** 0.0366*** 0.0266*** 0.0308*** -0.0874 0.0474*** 0.0282** 
